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Permeability transitionBAX cooperates with truncated BID (tBID) and Ca2+ in permeabilizing the outer mitochondrial membrane
(OMM) and releasing mitochondrial apoptogenic proteins. The mechanisms of this cooperation are still
unclear. Here we show that in isolated brain mitochondria, recombinant BAX readily self-integrates/
oligomerizes in the OMM but produces only a minuscule release of cytochrome c, indicating that BAX
insertion/oligomerization in the OMM does not always lead to massive OMM permeabilization. Ca2+ in a
mitochondrial permeability transition (mPT)-dependent and recombinant tBID in an mPT-independent
manner promoted BAX insertion/ oligomerization in the OMM and augmented cytochrome c release. Neither
tBID nor Ca2+ induced BAX oligomerization in the solution without mitochondria, suggesting that BAX
oligomerization required interaction with the organelles and followed rather than preceded BAX insertion in
the OMM. Recombinant Bcl-xL failed to prevent BAX insertion/oligomerization in the OMM but strongly
attenuated cytochrome c release. On the other hand, a reducing agent, dithiothreitol (DTT), inhibited BAX
insertion/oligomerization augmented by tBID or Ca2+ and suppressed the BAX-mediated release of
cytochrome c and Smac/DIABLO but failed to inhibit Ca2+-induced swelling. Altogether, these data suggest
that in brain mitochondria, BAX insertion/oligomerization can be dissociated from OMM permeabilization
and that tBID and Ca2+ stimulate BAX insertion/oligomerization and BAX-mediated OMM permeabilization
by different mechanisms involving mPT induction and modulation of the SH-redox state.drial permeability transition;
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Apoptosis is an omnipresent form of cell death involved in various
neurodevelopmental [1] as well as neuropathological processes,
including age-related neurodegenerations [2–6], stroke [7–10], and
secondary brain injury following mechanical brain trauma [11,12].
The release of mitochondrial apoptogenic factors, a key step in
executing of apoptosis [13], occurs due to a concert action of pro-
apoptotic proteins such as BID and BAX [14]. Under normalconditions, monomeric BAX and full-length BID are located in the
cytosol [15]. Caspase-8 activated by apoptotic stimuli cleaves BID,
producing activated (truncated) BID (tBID) [16]. In turn, tBID activates
BAX either “directly” [15,17,18] or “indirectly” [19,20] leading to
oligomerization of BAX, its insertion into the OMM, and OMM
permeabilization culminating in the release of mitochondrial apopto-
genic proteins [18,21].
In addition to tBID, elevated Ca2+ enhances the ability of BAX to
integrate into the lipid membranes and permeabilize them [22–24].
Ca2+ also ampliﬁes BAX ability to permeabilize the OMM [25], though
themechanism of such ampliﬁcation is unknown. Since elevated Ca2+
induces the mitochondrial permeability transition (mPT), a phenom-
enon accompanied by mitochondrial depolarization and remodeling
[26], it is possible that the mPT is involved in augmentation of BAX-
mediated OMM permeabilization. In cerebellar granule neurons,
trophic factor withdrawal in low-K+ medium resulted in the mPT
that triggered BAX translocation to mitochondria and release of Cyt c
[27]. In line with this, in the model of ischemia/reperfusion heart
injury, inhibition of the mPT either with Ru360, an inhibitor of the
mitochondrial Ca2+ uniporter [28], or with cyclosporin A (CsA), an
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OMM permeabilization [30]. Thus, there is evidence suggesting a
synergistic relationship between the Ca2+-induced mPT and BAX in
OMM permeabilization.
In the present study, we demonstrated that BAX could readily self-
integrate and oligomerize in the OMM, but these events were not
accompanied by massive Cyt c release. We also found that Ca2+ in an
mPT-dependent and tBID in anmPT-independent manner augmented
BAX insertion and oligomerization in the OMM that correlated with
the increased OMM permeabilization. Moreover, we showed that the
Ca2+- and tBID-stimulated BAX insertion/ oligomerization depended
on SH-redox state and could be inhibited by a reducing agent,
dithiothreitol (DTT). DTT also attenuated BAX-mediated OMM
permeabilization stimulated by Ca2+ or tBID, revealing an important
role of SH-redox regulation in the release of mitochondrial apopto-
genic proteins.
2. Materials and methods
2.1. Recombinant proteins
Full-length human monomeric BAX with a tag of six histidine
residues at the N-terminus was expressed in the pBAD plasmid in
Escherichia coli [31]. Mouse tBID (BID cut with caspase-8 and
separated from N-terminal and the caspase) was obtained from full-
length BID as described previously [32]. Recombinant Bcl-xL was
produced as described previously [17]. Recombinant BAX, tBID, and
Bcl-xL were stored in dialysis buffer containing 25 mM HEPES-NaOH,
pH 7.5, 0.2 mM dithiothreitol, 30% glycerol (v/v) at −86 °C.
2.2. Isolation and puriﬁcation of brain mitochondria
Mitochondria from the brains of male Sprague-Dawley rats, 200–
250 g (Harlan, Indianapolis, IN, USA) were isolated in mannitol-
sucrose medium according to an Institutional Animal Care and Use
Committee approved protocol and puriﬁed on a discontinuous Percoll
gradient as described previously [33]. Mitochondrial protein was
measured by the Bradford method [34], using BSA as a standard.
2.3. Measurements of mitochondrial light scattering
Mitochondrial swelling was evaluated in the standard incubation
medium at 37 °C by monitoring the scattering of light directed on
mitochondrial suspension under 90° to the axis of the photodetector
at 525 nm in a 0.4-ml cuvette under continuous stirring using a
PerkinElmer LS-55 luminescence spectrometer. The standard incuba-
tion medium used in these and other experiments contained 125 mM
KCl, 10 mMHEPES, pH 7.4, 0.5 mMMgCl2, 3 mMKH2PO4, 10 μMEGTA,
0.1% bovine serum albumin (free from fatty acids), 3 mM glutamate,
and 3 mM succinate.
2.4. Transmission electron microscopy
Electron microscopy of isolated brain mitochondria was per-
formed as described previously [35]. Mitochondria were incubated in
the standard 125 mM KCl-based medium at 37 °C prior to ﬁxation in
2% paraformaldehyde and 2% glutaraldehyde in 0.05 M phosphate
buffer in the same incubation medium at room temperature for
15 min. Transmission electron microscopy (TEM) images were taken
using a Tecnai G12 BioTwin electron microscope (FEI, Hillsboro, OR)
equipped with an AMT 2.6×2.6 K digital CCD camera.
2.5. Alkali-resistant BAX insertion
The alkali treatment of mitochondria removes loosely attached
proteins but leaves proteins inserted into the OMM [18]. Wedetermined the alkali-resistant fraction of BAX inserted into the
OMM using the earlier described method [36]. Brieﬂy, mitochondria
treated with BAX (50 or 150 nM) at 37 °C for 30 min were pelleted at
15,800g for 5 min, and supernatant was used for the Cyt c release
measurements. Mitochondrial pellets were re-suspended in 0.2 ml of
0.1 M Na2CO3, pH 11.5, then incubated for 30 min on ice. Samples
were centrifuged for 30 min at 100,000g in an Optima L-100 K
Beckman ultracentrifuge. The pellets were solubilized using 1% 3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS)
or 1% [octylphenoxy] polyethoxyethanol (Nonidet P-40, Amresco,
Solon, OH) and analyzed by western blotting against BAX and
cytochrome oxidase subunit IV (COX IV, loading control).
2.6. Immunoblotting
The release of Cyt c and Smac/DIABLO from isolated brain
mitochondria was assessed in supernatants obtained through incu-
bation of mitochondria in the standard 125 mM KCl-based incubation
medium with or without additions for 30 min at 37 °C. For SDS-PAGE,
we used 4–12% Bis-Tris gels (Invitrogen, Carlsbad, CA). Western
blotting was performed as previously described [37]. In some
experiments, alamethicin (30 μg/ml) was used to produce the
maximal Cyt c release. Mitochondrial cytochrome oxidase subunit IV
(COX IV) was used as a loading control for the pellet samples. COX IV
was detected with mouse monoclonal anti-COX IV antibody, dilution
1:5000 (Invitrogen, Carlsbad, CA). Following SDS-PAGE, proteins were
transferred to Hybond™-ECL™ nitrocellulose membrane (Amersham
Biosciences, Piscataway, NJ), and blots were incubated with mouse
anti-cytochrome c antibody (7H8.2C12, PharMingen, San Diego, CA)
at 1:3000 dilution or with rabbit anti-Smac/DIABLO antibody (Alexis
Biochemicals, San Diego, CA) at 1:1500 dilution for an hour at room
temperature in 5% non-fat milk, phosphate-buffered saline, pH 7.2,
and 0.15% Triton X-100. Prior to analysis of Smac/DIABLO release, the
supernatants were concentrated threefold in the Microcon YM-10
ﬁltering devices (Millipore Corporation, Bedford, MA). In the alkali-
resistant BAX insertion experiments, BAX was detected by western
blotting with rabbit polyclonal anti-BAX antibody (Upstate, Lake
Placid, NY). Recently, it was shown that oxidation of BAX's cysteines
favored formation of disulﬁde bridges and BAX oligomerization
[38,39], so it is possible that formation of disulﬁde bridges might
contribute to BAX oligomerization in our experiments. Correspond-
ingly, to prevent disruption of disulﬁde bridges and disassembly of
BAX oligomers, SDS-PAGE was performed under non-reducing
conditions. Anti-BAX antibody was used at 1:2000 dilution for an
hour at room temperature in 5% BSA (Jackson ImmunoResearch
Laboratories, West Grove, PA), phosphate-buffered saline, pH 7.2, and
0.15% Triton X-100. Blots were developed using goat anti-rabbit or
anti-mouse IgG (1:20000) coupled to horseradish peroxidase (Jack-
son ImmunoResearch Laboratories) and Supersignal West chemilu-
minescent reagents (Pierce, Rockford, IL). Molecular weight marker
SeeBlue® Plus 2 Standards (5 μl), (Invitrogen, Carlsbad, CA) were used
to determine the molecular weights of the bands. NIH ImageJ 1.40 g
software (http://rsb.info.nih.gov/ij/) was used to quantify band
densities. All immunoblots are representative of at least three
independent experiments.
2.7. Analytical gel-ﬁltration
Analytical gel-ﬁltration was carried out on a Superdex 200 HR 10/
30 column using FPLC. Prior to injecting into the column, BAX
(500 nM)was pre-incubated at 4 °C for 24 h in the solution containing
125 mM KCl, 10 mMHEPES, pH 7.4, and 1% CHAPS. The same solution
was used to equilibrate the column. After injecting the column with
150 μl sample, fractions of 0.4 ml were collected and protein was
concentrated with trichloroacetic acid/acetone precipitation prior to
analysis by western blotting. The column was calibrated using gel-
Fig. 1. Ca2+ and tBID failed to induce BAX oligomerization in the solution without
mitochondria. In a, 50 nM BAX was incubated in the standard mitochondrial incubation
medium with or without 250 μM Ca2+ for 30 min at room temperature (RT, 23 °C) or
37 °C as indicated. In b, 50 nM BAX was incubated with 20 or 60 nM tBID for 30 min at
37 °C in the standard incubation medium. In these and other experiments with BAX,
western blotting followed non-reducing SDS-PAGE.
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(2000 kDa), ferritin (440 kDa), catalase (232 kDa), albumin (66 kDa),
chymotrypsinogen A (25 kDa) (all from Sigma).
2.8. Protein cross-linking
Cross-linkers were dissolved in DMSO right before the experiment.
Ethylene glycol bis(succinimidyl succinate) (EGS, 0.2 mM), disucci-
nimidyl suberate (DSS, 0.2 mM), and bismaleimidohexane (BMH,
0.5 mM) (all from Pierce) were used. The cross-linkers were added to
the standard incubation medium supplemented with 50 nM BAX for
15 min at 37 °C. EGS and DSS were quenched by 20 mM Tris-HCl, pH
7.5, incubating with rocking for 30 min at room temperature. BMH
was quenched by 50 mMdithiothreitol (DTT) incubating with rocking
for 30 min at room temperature. Then, non-reducing SDS-PAGE and
western blotting were performed.
2.9. Statistics
Statistical analyses of experimental data consisted of a one-way
analysis of variance (ANOVA) followed by Bonferroni's post hoc test
(GraphPad Prism, version 4.0, GraphPad Software, San Diego, CA). The
data represent the mean±SEM of at least three independent
experiments.
3. Results
3.1. BAX insertion and oligomerization in the outer mitochondrial
membrane
The release of mitochondrial apoptogenic proteins depends on
BAX insertion/oligomerization in the OMM [17,18]. How Ca2+ and
tBID inﬂuence BAX insertion and oligomerization in the OMM of brain
mitochondria is unknown. In our study, we took advantage of isolated
puriﬁed brain mitochondria as a well-deﬁned, cell-free model system
that allows direct access to the OMM and precise control of the
experimental conditions. Importantly, the OMM represents a natural
target for pro-apoptotic proteins like BAX and tBID and contains all
necessary components involved to the release of mitochondrial
apoptogenic proteins. Thus, isolated brain mitochondria represent a
powerful experimental model perfectly suited for detailed analysis of
BAX insertion and oligomerization in the OMM and OMM
permeabilization.
The recombinant BAX used in our study was predominantly
monomeric with small amount of dimers (Fig. 1). Neither Ca2+ nor
tBID triggered BAX oligomerization in the solution prior to adding
mitochondria. Thus, BAX oligomerization required interaction of BAX
with the OMM and, hence, most likely followed rather than preceded
BAX insertion into the OMM. In the untreated mitochondria, the
amount of endogenous BAX was below the detection limit of western
blotting (Fig. 2a, lane 1). Incubation of mitochondria with BAX alone
produced alkali-resistant BAX insertion and oligomerization in the
OMM (Fig. 2a, lane 2), indicating that BAX can self-integrate and self-
oligomerize in the OMM producing various BAX oligomers. Both Ca2+
and tBID signiﬁcantly increased the amount of inserted/oligomerized
BAX (Fig. 2a–c). In these experiments, we used previously established
concentration of Ca2+ that produced distinct swelling of isolated brain
mitochondria but did not cause signiﬁcant Cyt c release in the
standard, 125 mM KCl-based incubation medium [33]. In some
western blotting experiments, the key samples were run in duplicate
to demonstrate reproducibility. Fig. 2b shows statistical analysis of
BAX insertion based on densitometry data obtained with individual
BAX bands (1×BAX–5×BAX) shown in Fig. 2a. Thus, BAX could self-
integrate/oligomerize in the OMM and both Ca2+ and tBID stimulated
these processes. Importantly, we did not use cross-linkers in our
experiments. In our hands, cross-linkers ethylene glycol bis(succini-midyl succinate) (EGS), disuccinimidyl suberate (DSS), and bismalei-
midohexane (BMH, all from Pierce) triggered BAX oligomerization in
the solution without mitochondria (Supplemental Fig. 1) and
therefore were unacceptable. In addition, in these experiments we
found that BSA-containing blocking solution was preferable for
detecting BAX oligomers than non-fat milk.
We used overnight incubation with 1% CHAPS at 4 °C to
solubilize mitochondrial pellets after alkali treatment (Fig. 2a).
For comparison, we also used 1% Nonidet P-40 (NP-40, Amresco,
Solon, OH), another non-ionic detergent, and detected the same
major bands corresponding to BAX oligomers (Fig. 2c). Importantly,
not all exogenous, recombinant BAX was inserted and oligomerized
in the OMM. A fraction of exogenous BAX (~35–40%) remained in
the incubation medium in the form of monomers and dimers
(Supplemental Fig. 2). Fig. 2d shows statistical analysis of BAX
insertion based on densitometry data obtained with individual BAX
bands (1×BAX–5×BAX) shown in Fig. 2c. In the experiments with
mitochondrial pellets solubilized with NP-40, we tested the
hypothesis that the mPT is involved in Ca2+-stimulated BAX
insertion/oligomerization in the OMM. A combination of CsA and
ADP, inhibitors of the mPT [40–42], added to mitochondria prior to
BAX attenuated BAX insertion and oligomerization stimulated by
Ca2+ (Fig. 2d, compare lanes 2 and 6 and lane 4). On the other
hand, CsA and ADP failed to attenuate tBID-stimulated BAX
insertion and oligomerization (Fig. 2d, compare lanes 3 and 5),
which is consistent with the insensitivity of tBID plus BAX-induced
Cyt c release to mPT inhibitors [37].
3.2. Effect of different detergents on BAX quaternary structure
In the experiments with NP-40, the amount of large BAX oligomers
(N190 kDa) was much smaller than in the experiments with CHAPS
(Fig. 2a, c). This suggested that either NP-40 disassembled the large BAX
oligomers (N190 kDa), or they were an artifact produced by interaction
of BAX with CHAPS. We tested several non-ionic detergents to evaluate
their ability to trigger BAX oligomerization. Previously, Antonsson et al.
(2000) reported that octyl glucoside (OG) caused BAX oligomerization
[43]. However, in our experiments we did not observe BAX oligomer-
izationwithOG. The reason for that is unclear butmightbe related to the
difference in experimental conditions. Our experiments revealed that
OG, Triton X-100 (Tr X-100), and NP-40 somewhat increased amounts
of BAX dimers and produced small amount of BAX trimers but failed to
trigger formation of larger BAX oligomers (Fig. 3a–d). CHAPS, on the
other hand, readily oligomerized BAX, producing various forms of BAX
Fig. 2. Recombinant BAX self-integrated and self-oligomerized in the outer mitochondrial membrane of isolated brain mitochondria. Ca2+ and tBID stimulated BAX insertion and
oligomerization. Cyclosporin A (CsA) and ADP antagonized the effect of Ca2+ but did not inﬂuence the effect of tBID. In a, alkali-resistant BAX insertion and oligomerization with and
without Ca2+ or tBID. Mitochondria were treated for 30 min at 37 °C with 50 nM BAX, with 1.4 μmol Ca2+/mg protein, or with 20 nM tBID as indicated. Following alkali treatment
(30 min on ice in 0.1 MNa2CO3 at pH 11.5),mitochondrialmembraneswere solubilizedwith 1% CHAPS. In c, alkali-resistant BAX insertion and oligomerizationwith andwithout Ca2+
or tBID and the effect of CsA plus ADP. Mitochondria were treated for 30 min at 37 °C with 50 nM BAX, with 1.4 μmol Ca2+/mg protein, with 20 nM tBID, and with a combination of
1 μMCsA and 100 μMADP (in the presence of 1 μMoligomycin to prevent ADP phosphorylation) as indicated. Following alkali treatment, mitochondrial membranes were solubilized
with 1% Nonidet P-40. p, pellets. In b and d, statistical analyses of BAX insertion into the OMM were performed using one-way ANOVA followed by Bonferroni's post-hoc test. The
graphs show the averaged sum of 1×BAX–5×BAX band densities under corresponding experimental conditions. Here and in all other similar experiments, the densitometry of
individual bands was performedwith NIH ImageJ 1.40 g software (http://rsb.info.nih.gov/ij/). Data are mean±SEM, N=3. In b, *pb0.05 comparing band densities with BAX versus
BAX plus tBID; **pb0.01 comparing band densities with BAX versus BAX plus Ca2+. In d, *pb0.01 comparing band densities with BAX versus BAX plus tBID or BAX plus Ca2+; #pb0.05
comparing band densities with BAX plus Ca2+ versus BAX plus Ca2+ with CsA and ADP. These and all other experiments with BAX were performed without cross-linkers.
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BAX oligomerization in the presence of CHAPS is not clear but, possibly,
this could be due to difference in experimental conditions used for
western blotting. For example, in our hands 5% non-fat milk, which is
alsoused bymany investigators as blocking solution inwestern blotting,
signiﬁcantly hindered detection of BAX oligomers produced by CHAPS
or by interaction of BAX with mitochondria. Interestingly, in the
experimentswith CHAPSweobserved an increase in the total amount of
BAX immunoreactive material over time despite equal protein loading
in every lane. The reason for this increase is unclear but it is possible that
in these experiments monomeric BAX bands were oversaturated and
this could obscure redistribution of BAX from monomeric band to the
bands corresponding to BAX oligomers.To conﬁrm that CHAPS induced BAX oligomerization, we performed
analytical gel-ﬁltration of BAX in 1% CHAPS solution (Fig. 3e, f). In these
experiments, we detected BAX in high molecular weight fractions,
indicating formation of large BAX oligomers. Notably, UV absorbance
measurements in the eluate revealed huge BAX aggregates with
molecular weights up to several megaDa (Fig. 3e, f). Thus, both SDS-
PAGE and analytical gel-ﬁltration conﬁrmed BAX oligomerization in the
solutionwithCHAPS. Overall, thesedata suggest that in the experiments
with alkali-resistant BAX insertion into theOMM,CHAPSmight produce
anartifact leading to formationof high-molecularweight BAXoligomers
(Fig. 2a). On the other hand, these results conﬁrmed that NP-40 did not
trigger BAX oligomerization and therefore in the following experiments
we used NP-40 to solubilize mitochondria.
Fig. 3. CHAPS but not Nonidet P-40, Triton X-100, or octyl glucoside produced oligomerization of BAX in the solution without mitochondria. Analytical gel-ﬁltration conﬁrmed BAX
oligomerization by CHAPS. In a–d, BAX (50 nM)was incubated for 0.5–24 h in the incubationmedium at 4 °C either with 1% octyl glucoside (OG), or 1% Triton X-100, or 1% Nonidet P-
40, or 1% CHAPS, or without detergent. In all cases, the amount of protein loaded on the gel was the same (100 ng/lane). In e and f, BAX (500 nM) was incubated with 1% CHAPS for
24 h at 4 °C. Larger BAX concentration was used to compensate dilution during gel-ﬁltration. Then, BAX incubated with the detergent was passed through a Superdex-200 HR 10/30
column equilibrated with 125 mM KCl, 10 mM HEPES, pH 7.4, and 1% CHAPS. In e, a UV absorbance (280 nm) proﬁle of the gel-ﬁltration eluate. a.u., arbitrary units. In f, western
blotting analysis of the collected fractions. Fr, fraction.
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In the next experiments, we evaluated whether BAX insertion/
oligomerization augmented by tBID and Ca2+ correlated with increased
OMMpermeabilization.WeexaminedCyt c release inducedbyBAXalone
or in combination with tBID or Ca2+. Notably, in these experiments,
isolated brain mitochondria retained OMM integrity and did not release
Cyt c spontaneously during incubation in the standard125 mMKCl-based
medium for 30 min at 37 °C (Fig. 4a, lane 1). BAX (50 nM) added alone
produced a minuscule Cyt c release (Fig. 4a, lane 3). Larger BAX
concentration (150 nM) resulted in a greater Cyt c release (Fig. 4a, lane
4) comparable with Cyt c release observed in our previous study [37].
Importantly, Ca2+ added alone to mitochondria failed to produce
substantial Cyt c release (Fig. 4a, lane 2). Similar observations were
reported earlier and were linked to insufﬁcient mitochondrial swelling
that was not extensive enough to rupture the OMM [33,44,45].
Nevertheless, Ca2+ signiﬁcantly augmented BAX-mediated Cyt c release
(Fig. 4a, lanes 5 and 6). A combination of 50 nM BAX and 20 nM tBID
producedanearly completeCyt c release (Fig. 4a, lane7). Pre-treatmentof
mitochondria with CsA plus ADP, inhibitors of the mPT [40–42],signiﬁcantly diminished Cyt c release induced by a combination of BAX
and Ca2+ (Fig. 4c, compare lanes 2 and 3). In these experiments,
alamethicin (30 μg/ml) was used as a positive control to produce
maximal Cyt c release (Fig. 4c, lane 4). Thus, our data suggested mPT
involvement in the Ca2+-induced stimulation of BAX-mediated OMM
permeabilization. However, it remained unclear whether Ca2+ ampliﬁed
membrane-permeabilizing activity of BAX, or BAX augmented Ca2+-
induced mitochondrial swelling resulting in OMM damage and Cyt c
release.
3.4. BAX does not augment Ca2+-induced mitochondrial swelling
To address this question, we evaluated mitochondrial volume
changes using 90° light scattering assay [46]. The untreated
mitochondria did not swell spontaneously during the course of the
experiment (Fig. 5a). At the end of the experiments, alamethicin
(30 μg/ml) was added to produce maximal swelling (Fig. 5a–d). BAX
(50 nM) alone failed to induce mitochondrial swelling (Fig. 5b). On
the other hand, Ca2+, an inducer of the mPT [47], produced large-
amplitude mitochondrial swelling, and CsA plus ADP completely
Fig. 4. Ca2+ ampliﬁed cytochrome c release induced by recombinant monomeric BAX. Cyclosporin A and ADP, inhibitors of the mitochondrial permeability transition, attenuated the
Ca2+ effect. In a, the effect of Ca2+ and tBID on cytochrome c (Cyt c) release induced by BAX. Where indicated, 250 μM Ca2+ (1.4 μmol Ca2+ per mg of mitochondrial protein) or
20 nM tBID was added. Here and in other experiments, COX IV was used as a loading control. In b, densitometry analysis of western blots performed with ImageJ software. The
densitometry results are shown as percentage of Cyt c release. The Cyt c release induced by 50 nM BAX plus 20 nM tBID was taken as 100%. Data are mean±SEM, *pb0.01 between
Cyt c release induced by 50 or 150 nM BAX alone or in the presence of 1.4 μmol Ca2+/mg protein, N=3. In c, a combination of cyclosporin A (CsA, 1 μM) and ADP (100 μM) (here and
in other similar experiments, ADP was added in the presence of 1 μM oligomycin, an inhibitor of ATP synthase, to prevent ADP phosphorylation) decreased Cyt c release induced by
50 nM BAX in the presence of 1.4 μmol Ca2+/mg protein. In these experiments, alamethicin (Alam, 30 μg/ml) was used to produce the maximal Cyt c release. In d, densitometry
analysis performed with ImageJ software. The densitometry results are shown as percentage of Cyt c release. The Cyt c release induced by 30 μg/ml alamethicin was taken as 100%.
Data are mean±SEM, *pb0.01 between Cyt c release induced by BAX plus Ca2+ in the absence or in the presence of CsA and ADP, N=4. In a and c, s, supernatants; p, pellets.
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BAX could increase the Ca2+-induced swelling, we incubated
mitochondria with BAX (50 nM) and then added Ca2+ (1.4 μmol/
mg protein) (Fig. 5d). To quantify our data, we measured the
amplitude of mitochondrial swelling induced by Ca2+ as a percentage
of maximal alamethicin-induced swelling taken as 100% (Fig. 5c).
These experiments showed that BAX did not increase the Ca2+-
induced mitochondrial swelling (Fig. 5e). Without BAX, Ca2+
(1.4 μmol/mg protein) produced 61±5.6% of maximal swelling
versus 63.2±4.9% with 50 nM BAX (mean±SEM, N=3).
Transmission electron microscopy (TEM) corroborated the results
obtained with light scattering assay. Following Ca2+ application,
mitochondrial matrices changed from condensed to predominantly
swollen (Fig. 5f, g). BAX (50 nM) failed to affect mitochondrial
morphology (Fig. 5h) and did not augment mitochondrial swellingFig. 5. Recombinant monomeric BAX did not cause mitochondrial swelling and failed to augm
of changes in mitochondrial volume obtained with or without Ca2+ and BAX. Here, 30 μg/m
1.4 μmol Ca2+/mg protein was added to mitochondria where indicated. In b, 50 nM BAX was
e, the extent of Ca2+-induced mitochondrial swelling with or without 50 nM BAX calculate
electron micrographs of isolated brain mitochondria incubated with or without Ca2+ and BA
(3 μl of the dialysis buffer for BAX (25 mMHEPES-NaOH, pH 7.5, 0.2 mM dithiothreitol, 30% g
for 30 min at 37 °C in the medium supplemented with 50 nM BAX. In g and i, the incubation m
of mitochondria incubated under the indicated conditions. Total mitochondrial populatio
swollen (S), and orthodox (O). The representative example of condensed morphology is sho
panel i. *pb0.001, comparing amount of condensed mitochondria with and without Ca2+; #
mean±SEM, N=3.induced by Ca2+ (Fig. 5i). In these experiments, we used the
morphometric analysis described previously [35,48]. Fig. 5j shows the
results of morphometric analysis of mitochondria incubated with or
without Ca2+ and BAX. These data indicated that BAX failed to augment
the Ca2+-induced swelling. Therefore, the non-speciﬁc damage of the
OMM appeared unlikely to be the mechanism of the increased Cyt c
release following combined application of BAX and Ca2+.
3.5. Alkali treatment and heating are not necessary for BAX
oligomerization in the OMM
High pH or heating of BAX samples above 43–47 °C could lead to
BAX oligomerization [49–51]. Correspondingly, there was a possibility
that BAX oligomerization in our experiments resulted from alkali
treatment of mitochondria or heating samples before SDS-PAGEent Ca2+-induced mitochondrial swelling. In a–d, 90º light scattering traces indicative
l alamethicin was added as indicated to cause maximal mitochondrial swelling. In c–d,
added as indicated. In d, 50 nM BAX was added to the cuvette prior to mitochondria. In
d as a percentage of maximal, alamethicin-induced swelling taken as 100% (c). In f–i,
X. In f and g, mitochondria were incubated without BAX, but were treated with a vehicle
lycerol (v/v)) in 300 μl of incubation medium). In h and i, mitochondria were incubated
ediumwas supplemented with 1.4 μmol Ca2+/mg protein. In j, morphometric analysis
n was categorized into three groups according to their morphology: condensed (C),
wn in the box in panel f; swollen (small box) and orthodox (large box) morphology in
pb0.001, comparing amount of swollen mitochondria with and without Ca2+. Data are
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Fig. 6. Alkali treatment of mitochondria and heating the samples before SDS-PAGEwere
not essential for detecting BAX oligomers. The experiments were performed as
described in the legend to Fig. 2 but without alkali treatment of mitochondria and
without heating the mitochondrial samples before SDS-PAGE. In a, mitochondria were
incubated for 30 min at 37 °C with 50 nM BAX in combination with 20 nM tBID or
1.4 μmol Ca2+/mg protein as indicated. Mitochondrial pellets were solubilized with 1%
Nonidet P-40. p, pellets. In b, statistical analysis of BAX insertion/oligomerization in the
OMMwas performed using one-way ANOVA followed by Bonferroni's post-hoc test. The
graph shows the averaged sum of 1×BAX–5×BAX band densities under corresponding
experimental conditions. Data are mean±SEM, N=3. In b, *pb0.01 comparing band
densities with or without BAX plus tBID or BAX plus Ca2+.
Fig. 7. Recombinant Bcl-xL inhibited cytochrome c release but failed to attenuate BAX
insertion and oligomerization in the outer mitochondrial membrane augmented by
Ca2+.Mitochondriaweretreatedfor30 minat37 °Cwith150 nMBAX,1.4 μmol Ca2+/mg
protein, and with 300 nM Bcl-xL as indicated. After 30 min of incubation, mitochondria
were pelleted by centrifugation and cytochrome c (Cyt c) release was evaluated in the
supernatants (a). In b, alkali-resistant BAX insertion was assessed in mitochondrial
membranes solubilized with 1% Nonidet P-40. s, supernatants, p, pellets. In c, the
statistical analysis of BAX insertion into the OMM was performed using one-way
ANOVA followed by Bonferroni's post-hoc test. The graph shows the averaged sum of
1×BAX–5×BAX band densities under corresponding experimental conditions. Data are
mean±SEM, N=3. *pb0.01 comparing band densities with BAX versus BAX plus Ca2+
or BAX plus Ca2+ and Bcl-xL. In d, the densitometry analysis of Cyt c release. Data are
mean±SEM, *pb0.05, **pb0.01, ***pb0.001 versus Cyt c release in the presence of Bcl-
xL alone.
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oligomerization without alkali-treatment of mitochondria and heat-
ing of samples for SDS-PAGE. In these experiments, we detected the
same pattern of BAX insertion/oligomerization in the OMM as we
observed in our standard experiments with alkali treatment of
mitochondria and heating of protein samples (Fig. 6). Interestingly,
without alkali treatment, we detected a new band with molecular
weight ~80 kDa in solubilized untreated mitochondria (Fig. 6, lane 1).
Fig. 8. Dithiothreitol attenuated BAX insertion/oligomerization and outer mitochondrial membrane permeabilization but failed to inhibit mitochondrial swelling induced by Ca2+.
Mitochondria were treated for 30 min at 37 °C with 50 nM BAX, with 1.4 μmol Ca2+/mg protein, and with 20 nM tBID as indicated. Where indicated, the incubation medium was
supplemented with 20 mM dithiothreitol (DTT). Then, mitochondria were pelleted by centrifugation and cytochrome c (Cyt c) and Smac/DIABLO (Smac) releases were evaluated in
the supernatants (a). In b, alkali-resistant BAX insertion was assessed in mitochondrial membranes solubilized with 1% Nonidet P-40. s, supernatants, p, pellets. In c, statistical
analysis of BAX insertion into the OMM was performed using one-way ANOVA followed by Bonferroni's post-hoc test. The graph shows the averaged sum of 1×BAX–5×BAX band
densities under corresponding experimental conditions. Data are mean±SEM, N=3. *pb0.01 comparing BAX band densities with or without 20 mM DTT. In d, the densitometry
analysis of Cyt c release. In e, the densitometry analysis of Smac/DIABLO (Smac) release. Data are mean±SEM, N=3, *pb0.01, **pb0.001 comparing Smac/DIABLO release in the
presence or absence of 20 mM DTT. In f, mitochondrial swelling followed with a 90º light scattering assay. Light scattering traces obtained with and without dithiothreitol (DTT,
20 mM) are overlapped for comparison. Where indicated, 1.4 μmol Ca2+/mg protein, and 30 μg/ml alamethicin (Alam) were added to mitochondria.
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mitochondria (Fig. 2a, d) and therefore might represent endogenous
BAX tetramers loosely attached to the OMM.
3.6. Effect of recombinant Bcl-xL on BAX insertion/oligomerization and
Cyt c release
In our experiments, recombinant Bcl-xL signiﬁcantly inhibited Cyt
c release induced by a combination of BAX and Ca2+ (Fig. 7a, compare
lanes 3 and 4). Fig. 7d shows statistical analysis of the Cyt c release.
Despite inhibition of Cyt c release, Bcl-xL failed to attenuate BAX
insertion and oligomerization in the OMM (Fig. 7b, compare lanes 3
and 4). Fig. 7c illustrates statistical analysis of BAX insertion based on
densitometry data obtained with individual BAX bands (1×BAX–
5×BAX) shown in Fig. 7b. Interestingly, using polyclonal anti-BAX
antibody, we detected a distinct band with a molecular weight
~30 kDa (Fig. 7b, lane 6), which corresponded to molecular weight of
Bcl-xL [52] and was strongly ampliﬁed after addition of exogenous
Bcl-xL (Fig. 7b, compare lanes 1 and 6). It is possible that this band
belonged to exogenous, recombinant Bcl-xL inserted into mitochon-
drial membranes in alkali-resistant manner.
3.7. Role of SH-redox state in BAX insertion/oligomerization and OMM
permeabilization
Oxidation of BAX's cysteines and formation of disulﬁde bridges
between BAX molecules favors BAX oligomerization and OMM
permeabilization [38,39]. In our experiments, a reducing agent
dithiothreitol (DTT, 20 mM) dismantled BAX dimers in the solution
without mitochondria (Supplemental Fig. 3). We hypothesized that
tBID- and Ca2+-stimulated BAX insertion/oligomerization in the
OMM and Cyt c release might depend on oxidation of SH-groups.
Indeed, DTT added into the standard incubation medium signiﬁcantly
diminished BAX insertion/oligomerization stimulated by tBID or Ca2+
(Fig. 8b, c, compare lanes 3 and 4 versus 7 and 8). DTT also
attenuated insertion/oligomerization of BAX in the absence of tBID or
calcium (Supplemental Fig. 4). In addition, DTT inhibited BAX-
mediated Cyt c release stimulated by Ca2+ and to a much lesser
extent by tBID (Fig. 8a, compare lanes 3 and 7 versus lanes 4 and 8)
but failed to inhibit Cyt c release induced by tBID alone (Fig. 8a,
compare lanes 2 and 6). On the other hand, DTT strongly inhibited the
release of Smac/DIABLO, another mitochondrial apoptogenic protein
with twice larger molecular weight than Cyt c [53,54], induced by tBID
alone or by a combination of tBID and BAX (Fig. 8a). Interestingly, a
combination of Ca2+ and BAX appeared to be ineffective in the release
of Smac/DIABLO. Fig. 8c shows statistical analysis of BAX insertion
shown in Fig. 8b. Fig. 8d and e shows statistical analysis of
densitometry data obtained with Cyt c and Smac/DIABLO bands
respectively. Importantly, DTT (20 mM) failed to inhibit mitochon-
drial swelling induced by Ca2+ (Fig. 8f) indicating that DTT effect
could not be attributed to inhibition of the mPT. Thus, these
experiments revealed for the ﬁrst time an important role of the SH-
redox state in the regulation of BAX insertion/oligomerization and in
BAX-mediated OMM permeabilization in brain mitochondria.
4. Discussion
It has been established in early studies that the extent of Cyt c
release correlates with the amount of BAX inserted in the OMM
[17,18]. In addition, early studies suggested that OMM permeabiliza-
tion required BAX oligomerization that occurred prior to BAX
insertion into the OMM [17,18], whereas monomeric BAX neither
integrated into the OMM nor released Cyt c [36]. In our study for the
ﬁrst time we clearly demonstrated that recombinant monomeric BAX
readily self-integrated into the OMM of brain mitochondria and self-
oligomerized. We found no evidence for tBID- or Ca2+-inducedoligomerization of BAX in the solution prior to interaction with
mitochondria. Accordingly, our results suggest that BAX most likely
integrates into the OMM as a monomer and that interaction of BAX
with the OMM is necessary for BAX oligomerization. Our ﬁndings are
consistent with reports showing that BAX insertion into the OMM or
liposomal membrane preceded the oligomerization step [55,56].
Importantly, the amount of BAX inserted into the OMM in the
absence of tBID or calciumwas relatively high (see Fig. 2a, lanes 2 and
4, and Fig. 2b, lane 1). On the other hand, the amount of BAX
oligomers (except dimers) in the BAX preparation was below the
detection limit of western blotting (Fig. 1). Therefore, the amount of
BAX inserted and oligomerized in the OMM did not correspond to the
amount of BAX oligomers in the BAX preparation.
In our experiments, BAX self-insertion and oligomerization in the
OMM resulted in a minute release of Cyt c. Our observation echoes
early ﬁndings and several recent reports indicating that BAX
translocation to mitochondria does not necessarily cause massive
OMM permeabilization [57–61]. Additional factors appeared to be
required for unleashing the permeabilizing activity of the membrane-
inserted and oligomerized BAX. Earlier, Epand et al (2002) reported
that the negative curvature in membranes that is essential for OMM
permeabilization was promoted by tBID [62]. Correspondingly, in our
experiments the lack of massive OMM permeabilization by BAX alone
could be explained by the lack of changes in the membrane curvature.
In our experiments, tBID and Ca2+ augmented BAX insertion/
oligomerization in the OMM and strongly ampliﬁed membrane-
permeabilizing activity of BAX. The Ca2+-dependent ampliﬁcation of
BAX activity is of particular interest. Bearing in mind that BAX can
cause Ca2+ efﬂux from the endoplasmic reticulum [63–66] and, hence,
increase the likelihood of the Ca2+-induced mPT [67], the Ca2+-
induced stimulation of BAX insertion/oligomerization in the
OMM leading to enhanced OMM permeabilization might represent a
feed-forward ampliﬁcation loop ensuring successful, irreversible
progression of the apoptotic program.
Previously, it was shown that Ca2+ stimulated BAX-mediated Cyt c
release from isolated liver mitochondria [25]. However, the mecha-
nism of this stimulation was not investigated further. In our study
with isolated brain mitochondria, we demonstrated that the Ca2+-
induced ampliﬁcation of the BAX-mediated Cyt c release occurred
parallel to augmented alkali-resistant BAX insertion/oligomerization
in the OMM, and that both BAX insertion/oligomerization in the OMM
and BAX-mediated Cyt c release were facilitated by mPT induction.
Thus, our results suggest augmented BAX insertion/oligomerization a
mechanistic link between the Ca2+-induced mPT and increased BAX-
mediated Cyt c release. In contrast to Ca2+, tBID-stimulated BAX
insertion, oligomerization, and Cyt c release appeared to be mPT-
independent, but in this case augmented BAX insertion/oligomeriza-
tion also correlated with the increased Cyt c release.
Anti-apoptotic Bcl-2, a close relative of Bcl-xL [68,69], can inhibit
pro-apoptotic BAX activity by heterodimerizing with BAX [70,71] or by
binding tBID and hence precluding tBID-dependent activation of BAX
[56,72]. Whether Bcl-xL/BAX heterodimerization affected BAX inser-
tion/oligomerization in the OMM or inhibited already inserted and
oligomerized BAX remained unclear. In our experiments, recombinant
anti-apoptotic protein Bcl-xL failed to prevent BAX insertion and
oligomerization in the OMM. However, Bcl-xL strongly inhibited Cyt c
release induced by a combination of BAX and Ca2+. Earlier, we showed
that recombinant Bcl-xL inhibited Cyt c release induced by a combi-
nation of tBID and monomeric BAX [73]. Thus, our results support a
scenario in which Bcl-xL inhibits inserted/oligomerized BAX and
emphasize the fact that BAX insertion/oligomerization in the OMM
could be dissociated from OMM permeabilization. How Bcl-xL restrains
the inserted/oligomerizedBAX frompermeabilizing theOMMhas yet to
be determined. It seems conceivable that Bcl-xL could bind to the
inserted/oligomerized BAX and physically block or disrupt the BAX
pore, leading to inhibition of the BAX-mediated OMMpermeabilization.
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often accompanied by an increase in ROS generation, and that
suppression of ROS generation might protect cells against apoptosis
[74–77]. Following ROS attack, critical SH-groups of different proteins
might be oxidized leading to formation of intra- and inter-molecular
disulﬁde bridges [78]. The exact role of the SH-redox state in the
membrane-permeabilizing activity of BAX is not clear yet but it is
possible that changes in intracellular SH-redox state could inﬂuence
BAX conformation and thus stimulate BAX insertion/oligomerization
in the OMM. Indeed, D'Alessio et al. demonstrated that oxidation of
cysteine residues of BAX resulted in formation of disulﬁde bridges,
causing conformational changes that favored BAX dimerization and
translocation to mitochondria [38]. In our study, a reducing agent DTT
inhibited tBID- and Ca2+-stimulated BAX insertion/oligomerization
in the OMM, but only in the latter case DTT signiﬁcantly suppressed
Cyt c release. This suggests that Ca2+-stimulated BAX-mediated Cyt c
release depends on oxidation of SH-groups whereas the tBID-
stimulated BAX-mediated Cyt c release does not. It is conceivable
that disruption of disulﬁde bridges between BAX molecules with DTT
underlies a decrease in BAX insertion/oligomerization in the OMM
affecting OMM permeability. Alternatively, DTT could antagonize the
Ca2+-inducedmPT [79] and hence hinder BAX-mediated Cyt c release.
However, in our experiments DTT failed to inhibit mitochondrial
swelling induced by Ca2+ ruling out this possibility.
The lack of correlation between diminished BAX insertion/
oligomerization and virtually unchanged Cyt c release observed with
tBID in the presence of DTT suggests that even small amounts of BAX
inserted and oligomerized in the OMMmight be sufﬁcient for massive
Cyt c release as proposed recently [80]. However, in our experiments,
self-insertion and self-oligomerization of BAX in the OMM failed to
induce massive Cyt c release, signifying a need for additional factors.
It is also conceivable that the size of BAX pores formed with tBID
remains large enough to pass Cyt c even in the presence of DTT
whereas conductance of the Ca2+-activated BAX pores declines more
signiﬁcantly with DTT making the pores less passable for Cyt c. Our
experiments with Smac/DIABLO release support this hypothesis.
Smac/DIABLO is approximately twice larger than Cyt c [53,54]. While
producing sizable Cyt c release, a combination of BAX and Ca2+ failed to
induce Smac/DIABLO release suggesting BAX pore size a limiting factor.
DTT,which failed to inhibit tBID-stimulated BAX-mediated Cyt c release,
at the same time strongly decreased the release of Smac/DIABLO. It is
possible that reduction of disulﬁdes with DTT affects not only insertion
and oligomerization of BAX and, correspondingly, the number of BAX
pores in theOMM, but also the size of the BAXpores. Thus, in addition to
the amount of BAX inserted/oligomerized in the OMM, modulation of
SH-redox statemight inﬂuencemolecular architecture of BAXoligomers
that could be critical for effective OMM permeabilization.
Overall, our results strongly suggest that BAX-mediated OMM
permeabilization in brain mitochondria can be modulated by the mPT
and by SH-redox state. Correspondingly, induction of the mPT,
increased ROS generation, and oxidation of critical SH-groups could
signiﬁcantly augment BAX-mediated permeabilization of the OMM
and thus promote neuronal apoptosis in various neurodegenerative
diseases, stroke, and traumatic brain injury.
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